The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil

BACKGROUND: The WHO established targets for 2030 to globally reduce new viral hepatitis B and C infections by 90% and deaths by 65% and recommends searching for coinfections that increase the progression of chronic liver infections towards cirrhosis and hepatocellular carcinoma. AIMS AND METHODOLOGY...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Karoline Rodrigues, Alves, Fabiana Aparecida, Lemos, Marcílio Figueiredo, Moreira, Regina Célia, Marcusso, Rosa Maria Nascimento, Caterino-de-Araujo, Adele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274452/
https://www.ncbi.nlm.nih.gov/pubmed/32453768
http://dx.doi.org/10.1371/journal.pntd.0008245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274452/
https://www.ncbi.nlm.nih.gov/pubmed/32453768
http://dx.doi.org/10.1371/journal.pntd.0008245

Ejemplares similares